- Investing Ideas
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
16
High return on equity, past performance and sound balance sheet.
16 companies
Sanofi Consumer Healthcare India
Market Cap: ₹95.5b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,217.70
7D
-1.4%
1Y
-11.2%
Pharma Mar
Market Cap: €1.5b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€86.65
7D
0.2%
1Y
-2.5%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹391.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,321.60
7D
-4.7%
1Y
-17.7%
Abbott India
Market Cap: ₹570.0b
Operates as a pharmaceutical company in India.
500488
₹26,397.30
7D
0.4%
1Y
-13.7%
Highnoon Laboratories
Market Cap: PK₨47.9b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨903.98
7D
2.7%
1Y
1.6%
GlaxoSmithKline Pakistan
Market Cap: PK₨103.5b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨324.88
7D
5.2%
1Y
-22.1%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.0b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س97.85
7D
0.7%
1Y
-24.3%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س9.7b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س141.10
7D
1.4%
1Y
-7.9%
Exelixis
Market Cap: US$10.8b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$41.57
7D
-0.6%
1Y
10.2%
Consun Pharmaceutical Group
Market Cap: HK$13.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.19
7D
-6.5%
1Y
84.2%
Chugai Pharmaceutical
Market Cap: JP¥13.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,453.00
7D
-5.9%
1Y
19.2%
Rigel Pharmaceuticals
Market Cap: US$489.5m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$26.13
7D
-0.9%
1Y
38.2%
HBM Holdings
Market Cap: HK$9.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.18
7D
-2.2%
1Y
45.5%
Gubra
Market Cap: DKK 5.9b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 360.00
7D
-7.7%
1Y
-24.7%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.4b
Engages in the pharmaceutical business in China.
000915
CN¥31.80
7D
-4.2%
1Y
10.1%
Blue Jet Healthcare
Market Cap: ₹60.4b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹353.40
7D
-7.8%
1Y
-58.6%